Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
amoxicillin (as amoxicillin trihydrate) clavulanic acid (as potassium clavulanate, diluted with microcrystalline cellulose (1:1))
Chanelle Animal Health Ltd.
QJ01CR02
50 Milligram
Tablets
Canine Feline
Antibiotics
Authorised
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Clavucill Tablets 50 mg. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Tablet. Pale pink, bi-convex, divisible tablet, scored on one face. The tablets can be divided into equal halves. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats & Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Clinically, amoxicillin has been shown to be effective in treating a wide range of diseases of cats and dogs including: skin disease (including deep and superficial pyoderma); urinary tract infection; respiratory disease involving upper and lower respiratory tract; enteritis; dental infections (e.g. gingivitis); soft tissue infections (e.g. abscesses and anal sacculitis). 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active substances. This product should not be given to rabbits, guinea pigs, hamsters or gerbils. Caution is advised in their use in any other very small herbivores. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Each tablet contains: ACTIVE INGREDIENTS Amoxicillin (as amoxicillin trihydrate) 40 mg Clavulanic acid (as potassium clavulanate) 10 mg EXCIPIENTS Contains Erythrosine (E127) 0.05 mg For a full list of excipients, see section 6.1 HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 30/07/2014_ _CRN 7017635_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS This product is not indicated for cases involving _Pseudomonas spp._ Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to penicillins and may decrease the effectiveness of treatment with other antim Read the complete document